YI
111, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · CN
$3.47
+4.05%Margins
Gross margin
5.7%
EBITDA margin
-0.1%
EBIT margin
-0.2%
Net margin
-0.7%
FCF margin
-0.8%
70.4%
Return on equity
-26.9%
Return on assets
40.7%
Return on invested capital
9.14x
Asset turnover
-$12.7M
Cash from operations
$0.90
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026